PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-May-2025 Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
12-May-2025 Formycon reports strong operational performance and financial results for first quarter of 2025 Formycon AG
09-May-2025 Lonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved Lonza Group AG
09-May-2025 Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX Drägerwerk AG & Co. KGaA
09-May-2025 Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025 Lonza Group AG
08-May-2025 DocMorris AG shareholders approve capital increase and all proposals put forward by the Board of Directors DocMorris AG
08-May-2025 Marinomed Biotech AG announces results for the first quarter of 2025 Marinomed Biotech AG
08-May-2025 RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed RHÖN-KLINIKUM Aktiengesellschaft
08-May-2025 DocMorris announces final details on the agenda of today's Annual General Meeting and the planned capital increase DocMorris AG
08-May-2025 Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited
07-May-2025 Annual General Meeting of SKAN Group AG approves all proposals SKAN AG
07-May-2025 Medacta announces the results of today's Annual General Meeting Medacta Group SA
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
07-May-2025 Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences Formycon AG
07-May-2025 Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE
07-May-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit. AEVIS VICTORIA SA
07-May-2025 Modern Dental Group Celebrates the Successful Conclusion of the  “Transformative Power of Digital Dentistry” Symposium 2025 Modern Dental Group Limited
06-May-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network AEVIS VICTORIA SA
06-May-2025 Conference call on the results for the 2nd quarter 2024/2025 (ending 31 March 2025) on 15 May 2025 Douglas AG
06-May-2025 aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region aap Implantate AG